AbstractAbout 90% of corneal infections are bacterial in origin. The most common pathogens are Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae and Pseudomonas aeruginosa. The two main causes of bacterial keratitis are contact lens usage and corneal injury.Patients typically complain of pain, sensitivity to light, blurred vision, tearing and yellowish purulent discharge. Clinical signs of bacterial keratitis include epithelial defect, ulceration in addition, stromal oedema and infiltrates with indistinct margins are present. Purulent material may appear in the anterior chamber.Most cases can be successfully treated with empiric therapy. If the pathogen is not known, moxifloxacin or cefazolin with tobramycin or gentamycin recommended as primary treatment. For severe keratitis eye drops should be applied both day and night for the first 48 hours. If the causative agent and its susceptibility are available from the microbiological sample and/or from smear, the topical treatment should be adjusted accordingly. If no improvement in the clinical picture seen after 48 hours with topical treatment, repeat sampling for microbiological culture recommended. In case of further progression, keratectomy with histological evaluation of the specimen is necessary. Corticosteroids may be considered after 48 hours when the infective organism is identified, and the keratitis is responding to therapy.In addition to antimicrobial treatment pupillary dilation advised to immobilize the iris and ciliary body. Cycloplegia may also decrease pain as well as synechia formation. In therapy resistant cases crosslinking may be an additional option if herpetic origin can be excluded.If the clinical picture does not improve, it is important to reassess the differential diagnosis of the keratitis caused by herpetic, fungal and Acanthamoeba infection.In cases of non‐healing and rapidly progressive corneal inflammation or ulceration, therapeutic corneal transplantation is recommended. However, surgery has a better prognosis in the non‐inflammatory period when the eye is quiet.